Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127586151 | 12758615 | 1 | I | 20160807 | 20160912 | 20160919 | 20160919 | EXP | FR-PFIZER INC-2016428325 | PFIZER | 77.00 | YR | F | Y | 0.00000 | 20160919 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127586151 | 12758615 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | UNK | Y | 21446 | |||||||||
| 127586151 | 12758615 | 2 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | Oral | 1 G, UNK | Y | 0 | 1 | G | |||||||
| 127586151 | 12758615 | 3 | SS | CLINDAMYCIN HYDROCHLORIDE. | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | UNK | Y | 0 | |||||||||
| 127586151 | 12758615 | 4 | SS | LASILIX /00032601/ | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 127586151 | 12758615 | 5 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | Subcutaneous | UNK | Y | 0 | |||||||||
| 127586151 | 12758615 | 6 | SS | NEFOPAM HYDROCHLORIDE | NEFOPAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 127586151 | 12758615 | 7 | SS | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | UNK | Y | 0 | |||||||||
| 127586151 | 12758615 | 8 | SS | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | UNK | Y | 0 | |||||||||
| 127586151 | 12758615 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | UNK | 0 | ||||||||||
| 127586151 | 12758615 | 10 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127586151 | 12758615 | 1 | Pain |
| 127586151 | 12758615 | 2 | Erysipelas |
| 127586151 | 12758615 | 3 | Erysipelas |
| 127586151 | 12758615 | 4 | Respiratory failure |
| 127586151 | 12758615 | 5 | Thrombosis prophylaxis |
| 127586151 | 12758615 | 6 | Pain |
| 127586151 | 12758615 | 9 | Prophylaxis |
| 127586151 | 12758615 | 10 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127586151 | 12758615 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127586151 | 12758615 | Rash maculo-papular | |
| 127586151 | 12758615 | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127586151 | 12758615 | 1 | 20160806 | 20160814 | 0 | |
| 127586151 | 12758615 | 2 | 20160801 | 20160807 | 0 | |
| 127586151 | 12758615 | 3 | 20160801 | 20160807 | 0 | |
| 127586151 | 12758615 | 4 | 20160731 | 20160808 | 0 | |
| 127586151 | 12758615 | 5 | 20160803 | 20160816 | 0 | |
| 127586151 | 12758615 | 6 | 20160803 | 20160811 | 0 | |
| 127586151 | 12758615 | 7 | 20160803 | 20160819 | 0 | |
| 127586151 | 12758615 | 8 | 20160803 | 20160819 | 0 | |
| 127586151 | 12758615 | 9 | 20160816 | 0 |